Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Finding the right balance on the challenging path to clinical translation of anti-inflammatory therapies for ischemic heart disease

Nature Cardiovascular Research volume 3, pages 245–247 (2024)Cite this article

Subjects

Although anti-inflammatory drugs have shown promising results in preclinical cardiovascular research, they have yielded little benefit in clinical trials. Before we can expect positive outcomes, we need to find ways of stratifying patients based on their infectious, inflammatory and autoimmune profile, and identify the right time of treatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Finding the right balance.

References

  1. Everett, B. M. et al. Am. Heart J. 166, 199–207.e15 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ridker, P. M. et al. N. Engl. J. Med. 377, 1119–1131 (2017).

    Article  CAS  PubMed  Google Scholar 

  3. Tardif, J.-C. et al. N. Engl. J. Med. 381, 2497–2505 (2019).

    Article  CAS  PubMed  Google Scholar 

  4. Abbate, A. et al. Am. J. Cardiol. 111, 1394–1400 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Schulz, T. F. Int. J. Cancer 125, 1755–1763 (2009).

    Article  CAS  PubMed  Google Scholar 

  6. Ridker, P. M. et al. Lancet 390, 1833–1842 (2017).

    Article  CAS  PubMed  Google Scholar 

  7. Kreiner, E. et al. J. Allergy Clin. Immunol. 140, 771–781 (2017).

    Article  CAS  PubMed  Google Scholar 

  8. Piché, M.-E., Tchernof, A. & Després, J.-P. Circ. Res. 126, 1477–1500 (2020).

    Article  PubMed  Google Scholar 

  9. Ridker, P. M. Lancet 391, 319–328 (2018).

    Article  CAS  PubMed  Google Scholar 

  10. Abplanalp, W. et al. Eur. Heart J. 44, (2023).

  11. Rieckmann, M. et al. J. Clin. Invest. 129, 4922–4936 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Sattler, S. ESC Hear. Fail. https://doi.org/10.1002/ehf2.14636 (2023).

    Article  Google Scholar 

  13. Mallat, Z. & Binder, C. J. Nat. Cardiovasc. Res. 1, 431–444 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Sicklinger, F. et al. Circ. Res. 127, 1214–1216 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Forte, E. et al. J. Cell. Mol. Med. 25, 229–243 (2021).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The thoughts presented in this Comment have been refined through many conversations with like-minded fellow cardioimmunologists. In particular, I would like to acknowledge G. Campos Ramos, M. Kallikourdis and P. Alcaide. This work was supported by funding from the Austrian Science Fund (P36588-B), the British Heart Foundation (P84083), and the Leducq Foundation.

Author information

Authors and Affiliations

  1. National Heart and Lung Institute, Imperial College London, London, UK

    Susanne Sattler

  2. Department of Pharmacology, Otto-Loewi Research Center, Medical University of Graz, Graz, Austria

    Susanne Sattler

  3. Department of Cardiology, LKH Univ. Klinikum Graz, Medical University of Graz, Graz, Austria

    Susanne Sattler

Authors
  1. Susanne Sattler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susanne Sattler.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sattler, S. Finding the right balance on the challenging path to clinical translation of anti-inflammatory therapies for ischemic heart disease. Nat Cardiovasc Res 3, 245–247 (2024). https://doi.org/10.1038/s44161-024-00440-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44161-024-00440-0

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing